Acadia Pharmaceuticals (ACAD) Minority Interest (2012 - 2013)
Acadia Pharmaceuticals' (ACAD) quarterly Minority Interest came in at $10.7 million in Q3 2013, down 39.64% quarter-over-quarter from $17.7 million in Q2 2013.
Acadia Pharmaceuticals (ACAD) Minority Interest (2012 - 2013) Analysis & Trends
Acadia Pharmaceuticals' Minority Interest history runs 2 years deep, the most recent figure standing at $10.7 million for Q3 2013.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $10.7 million in Q3 2013; TTM through Sep 2013 was $10.7 million, a N/A change from a year earlier, with the FY2012 full-year figure at $17.7 million, changed N/A from the prior year.
- Minority Interest fell to $10.7 million in Q3 2013 per ACAD's latest filing, from $17.7 million in the prior quarter.
- Across five years, Minority Interest topped out at $17.7 million in Q4 2012 and bottomed at $10.7 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Acadia Pharmaceuticals | 4.23 Bn | 3.38 Bn | 243.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2013 | 10.66 Mn |
| Jun 30, 2013 | 17.66 Mn |
| Mar 31, 2013 | 17.66 Mn |
| Dec 31, 2012 | 17.66 Mn |